Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
161
Employees161
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
161
Employees161

LYEL Key Statistics

Market cap
309.12M
Market cap309.12M
Price-Earnings ratio
-0.99
Price-Earnings ratio-0.99
Dividend yield
Dividend yield
Average volume
138.04K
Average volume138.04K
High today
$12.96
High today$12.96
Low today
$12.48
Low today$12.48
Open price
$12.83
Open price$12.83
Volume
89.63K
Volume89.63K
52 Week high
$45.00
52 Week high$45.00
52 Week low
$9.28
52 Week low$9.28

Stock Snapshot

With a market cap of 309.12M, Lyell Immunopharma(LYEL) trades at $12.63. The stock has a price-to-earnings ratio of -0.99.

As of 2026-07-25, Lyell Immunopharma(LYEL) stock has fluctuated between $12.48 and $12.96. The current price stands at $12.63, placing the stock +1.2% above today's low and -2.5% off the high.

The Lyell Immunopharma(LYEL)'s current trading volume is 89.63K, compared to an average daily volume of 138.04K.

During the past year, Lyell Immunopharma(LYEL) stock moved between $9.28 at its lowest and $45.00 at its peak.

During the past year, Lyell Immunopharma(LYEL) stock moved between $9.28 at its lowest and $45.00 at its peak.

LYEL News

TipRanks 4d
Lyell Immunopharma initiated with a Buy at B. Riley

B. Riley initiated coverage of Lyell Immunopharma (LYEL) with a Buy rating and $44 price target Lyell is a registrational-stage oncology company with two cell t...

Investing.com 4d
Innovative cellular therapeutics, Lyell director, sells $137 in stock - Investing.com

...

Innovative cellular therapeutics, Lyell director, sells $137 in stock - Investing.com

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
0%
Sell
14.3%

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.